Suppr超能文献

人血浆前激肽释放酶(激肽释放酶原)-激肽释放酶酶系统的研究。II. 关于高岭土激活的精氨酸酯酶与血浆激肽释放酶关系的证据。

Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.

作者信息

Colman R W, Mattler L, Sherry S

出版信息

J Clin Invest. 1969 Jan;48(1):23-32. doi: 10.1172/JCI105971.

Abstract

Evidence is presented in this paper that the kaolin-activated arginine esterase of plasma is related to plasma kallikrein activity. Such a relationship is based on studies that (1) establish a constant ratio of esterase activity on various synthetic substrates for the kaolin-activated arginine esterase, purified kallikrein(s), and preparations obtained during the fractionation procedure; (2) exclude other known plasma and tissue arginine esterases; (3) confirm the requirement for factor XII in the activation of the enzyme precursor; and (4) show similarities in behavior between the plasma esterase and purified kallikrein(s) toward a variety of inhibitors. Based on this probable identification, evidence is provided that the concentration of active factor XII determines the rate of activation of plasma kallikreinogen, and that the activation may be blocked by polybrene. Once activated, plasma kallikrein is rapidly inactivated by the naturally occurring plasma inhibitor, but the inhibition is incomplete. Acid or chloroform treatment of plasma rapidly inactivates the plasma inhibitor without affecting the concentration of plasma kallikreinogen. Another plasma arginine esterase with properties suggestive of permeability factor is activated by factor XII in the presence of synthetic substrates, but only at low ionic strength. The data suggest that this enzyme is closely related to plasma kallikrein and that it arises from a common precursor.

摘要

本文提供的证据表明,血浆中高岭土激活的精氨酸酯酶与血浆激肽释放酶活性相关。这种关系基于以下研究:(1)确定了高岭土激活的精氨酸酯酶、纯化的激肽释放酶以及分级分离过程中获得的制剂对各种合成底物的酯酶活性的恒定比例;(2)排除了其他已知的血浆和组织精氨酸酯酶;(3)证实了因子 XII 在酶原激活中的必要性;(4)显示了血浆酯酶和纯化的激肽释放酶对多种抑制剂的行为相似性。基于这种可能的鉴定,提供的证据表明,活性因子 XII 的浓度决定了血浆激肽释放酶原的激活速率,并且该激活可能被聚凝胺阻断。一旦被激活,血浆激肽释放酶会迅速被天然存在的血浆抑制剂灭活,但这种抑制并不完全。用酸或氯仿处理血浆会迅速使血浆抑制剂失活,而不影响血浆激肽释放酶原的浓度。另一种具有提示渗透因子性质的血浆精氨酸酯酶在合成底物存在下被因子 XII 激活,但仅在低离子强度下。数据表明,这种酶与血浆激肽释放酶密切相关,并且它来自共同的前体。

相似文献

7
Immunochemical studies of plasma kallikrein.血浆激肽释放酶的免疫化学研究。
J Clin Invest. 1974 Dec;54(6):1444-54. doi: 10.1172/JCI107892.

引用本文的文献

7
Immunochemical studies of plasma kallikrein.血浆激肽释放酶的免疫化学研究。
J Clin Invest. 1974 Dec;54(6):1444-54. doi: 10.1172/JCI107892.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验